Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jul;15(4):445-6.
doi: 10.1038/aja.2013.57. Epub 2013 May 20.

Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more

Affiliations
Comment

Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more

Mark Ng Tang Fui et al. Asian J Androl. 2013 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Intermittent versus continuous androgen deprivation in prostate cancer.
    Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr. Hussain M, et al. N Engl J Med. 2013 Apr 4;368(14):1314-25. doi: 10.1056/NEJMoa1212299. N Engl J Med. 2013. PMID: 23550669 Free PMC article. Clinical Trial.

Similar articles

References

    1. Grossmann M, Zajac JD. Management of side effects of androgen deprivation therapy. Endocrinol Metab Clin North Am. 2011;40:655–71. - PubMed
    1. Grossmann M, Zajac JD. Hematological changes during androgen deprivation therapy. Asian J Androl. 2012;14:187–92. - PMC - PubMed
    1. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, et al. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer. 1993;71:2782–90. - PubMed
    1. Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, et al. Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med. 2013;368:1314–25. - PMC - PubMed
    1. Crook JM, O'Callaghan CJ, Duncan G, Dearnaley DP, Higano CS, et al. Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med. 2012;367:895–903. - PMC - PubMed

MeSH terms